Literature DB >> 22398846

FDG-PET/CT-based gross tumor volume contouring for radiation therapy planning: an experimental phantom study.

Ryo Toya1, Ryuji Murakami, Kuniyuki Tashiro, Morikatsu Yoshida, Fumi Sakamoto, Koichi Kawanaka, Shinya Shiraishi, Yuji Nakaguchi, Naoko Tsujita, Natsuo Oya, Seiji Tomiguchi, Yasuyuki Yamashita.   

Abstract

As there is continuing controversy over the role of F-18-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT-fused imaging in radiation therapy (RT) planning, we performed a phantom study to assess the feasibility of FDG-PET/CT-based gross tumor volume (GTV) contouring. The phantom set, consisting of an elliptical bowl and 6 spheres measuring from 10-37 mm in diameter, were filled with FDG to obtain 3 source-to-background ratios (SBRs) of 4, 8, and 16. The ratio to maximum intensity at 5% intervals was applied as the threshold for contouring. The ratio between contoured- and actual volumes (volume ratio) was calculated, and the threshold ratio was selected to provide a volume ratio close to 100%. To consider the clinical application, we applied the threshold value (maximum intensity × threshold ratio) for the largest 37-mm sphere to the 6 spheres. The threshold ratio and the volume ratio in 6 spheres with 3 SBRs were compared using the Friedman test. Threshold ratios ranged from 25-80%; they were higher for smaller spheres (p = 0.003) and lower SBRs (p < 0.001). The volume ratios with the threshold value for the largest 37-mm sphere were lower in smaller spheres (p = 0.010). These results suggest that smaller lesions and higher background activities require a higher threshold ratio and smaller lesions a lower threshold value. FDG-PET/CT-fused imaging should not be used as a single modality but rather to obtain supplemental information in RT planning. The contoured GTV should be adjusted based on clinical data including conventional images.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398846     DOI: 10.1269/jrr.10183

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  4 in total

1.  The use of positron emission tomography/computed tomography imaging in radiation therapy: a phantom study for setting internal target volume of biological target volume.

Authors:  Wataru Kawakami; Akihiro Takemura; Kunihiko Yokoyama; Kenichi Nakajima; Syoichi Yokoyama; Kichiro Koshida
Journal:  Radiat Oncol       Date:  2015-01-08       Impact factor: 3.481

2.  Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation.

Authors:  Ryo Toya; Tomohiko Matsuyama; Tetsuo Saito; Masanori Imuta; Shinya Shiraishi; Yoshiyuki Fukugawa; Ayumi Iyama; Takahiro Watakabe; Fumi Sakamoto; Noriko Tsuda; Yoshinobu Shimohigashi; Yudai Kai; Ryuji Murakami; Yasuyuki Yamashita; Natsuo Oya
Journal:  J Radiat Res       Date:  2019-05-01       Impact factor: 2.724

3.  Prevalence and risk factors of retro-styloid lymph node metastasis in oropharyngeal carcinoma.

Authors:  Ryo Toya; Tetsuo Saito; Yoshiyuki Fukugawa; Tomohiko Matsuyama; Tadashi Matsumoto; Shinya Shiraishi; Daizo Murakami; Yorihisa Orita; Toshinori Hirai; Natsuo Oya
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

4.  Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.

Authors:  Ryo Toya; Tetsuo Saito; Kohsei Yamaguchi; Tomohiko Matsuyama; Takahiro Watakabe; Tadashi Matsumoto; Ryoji Yoshida; Akiyuki Hirosue; Daizo Murakami; Yorihisa Orita; Hideki Nakayama; Natsuo Oya
Journal:  Radiat Oncol       Date:  2020-05-27       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.